U. Paulus

BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group.

Volker Diehl, Jeremy Franklin, Dirk Hasenclever et al. · Journal of Clinical Oncology · 1998 · 196 citations

Medicine, Oncology, Pharmacotherapy +15

Classical Hodgkin's disease. Clinical impact of the immunophenotype.

Reinhard von Wasielewski, Michael Mengel, R. Fischer et al. · PubMed · 1997 · 142 citations

Medicine, Immunology, Pathology +10

A model of the control of cellular regeneration in the intestinal crypt after perturbation based solely on local stem cell regulation

U. Paulus, C. S. Potten, Markus Loeffler · Cell Proliferation · 1992 · 99 citations

Life Sciences, Biology, Cell Biology +15

Clonality and Life Cycles of Intestinal Crypts Explained by a State Dependent Stochastic Model of Epithelial Stem Cell Organization

Markus Loeffler, T. Bratke, U. Paulus et al. · Journal of Theoretical Biology · 1997 · 86 citations

Life Sciences, Biology, Cell Biology +17

14-Day Variant of the Bleomycin, Etoposide, Doxorubicin, Cyclophosphamide, Vincristine, Procarbazine, and Prednisone Regimen in Advanced-Stage Hodgkin’s Lymphoma: Results of a Pilot Study of the German Hodgkin’s Lymphoma Study Group

M. Sieber, Henning Bredenfeld, Andreas Josting et al. · Journal of Clinical Oncology · 2003 · 85 citations

Medicine, Oncology, Pharmacology +13